We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
-3.16%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$177B
AUM Growth
+$11.2B
Cap. Flow
+$20.2B
Cap. Flow %
11.39%
Top 10 Hldgs %
27.51%
Holding
2,722
New
3
Increased
2,642
Reduced
23
Closed
31

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.38B
2
MSFT icon
Microsoft
MSFT
+$1.13B
3
AMZN icon
Amazon
AMZN
+$756M
4
TSLA icon
Tesla
TSLA
+$466M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$431M

Sector Composition

Rank Sector Weight
1 Technology 28.22%
2 Healthcare 14.23%
3 Consumer Discretionary 13.07%
4 Communication Services 9.53%
5 Industrials 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLD icon
2676
Prelude Therapeutics
PRLD
$456M
$205K ﹤0.01%
29,700
+2,200
+8% +$20.1K
ICVX
2677
DELISTED
Icosavax, Inc. Common Stock
ICVX
$195K ﹤0.01%
27,700
+1,600
+6% +$25.2K
AMTI
2678
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$191K ﹤0.01%
25,400
ELMS
2679
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
$189K ﹤0.01%
131,900
+9,000
+7% +$29.3K
CURI icon
2680
CuriosityStream
CURI
$166M
$185K ﹤0.01%
63,700
PASG icon
2681
Passage Bio
PASG
$14.8M
$184K ﹤0.01%
2,975
HMTV
2682
DELISTED
Hemisphere Media Group, Inc.
HMTV
$178K ﹤0.01%
38,900
+3,200
+9% +$19.2K
GOCO
2683
DELISTED
GoHealth
GOCO
$160K ﹤0.01%
9,047
+634
+8% +$19.7K
ANNX icon
2684
Annexon
ANNX
$873M
$149K ﹤0.01%
54,500
+3,900
+8% +$24K
STTK icon
2685
Shattuck Labs
STTK
$752M
$137K ﹤0.01%
32,200
AXDX
2686
DELISTED
Accelerate Diagnostics
AXDX
$123K ﹤0.01%
8,530
+1,360
+19% +$38.7K
ALGS icon
2687
Aligos Therapeutics
ALGS
$43.7M
$121K ﹤0.01%
2,248
AWH
2688
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$115K ﹤0.01%
7,387
OLMA icon
2689
Olema Pharmaceuticals
OLMA
$913M
$93K ﹤0.01%
21,800
APLT
2690
DELISTED
Applied Therapeutics
APLT
$79K ﹤0.01%
37,300
BOLT icon
2691
Bolt Biotherapeutics
BOLT
$6.63M
$77K ﹤0.01%
1,400
API
2692
Agora
API
$379M
-113,464
Closed -$1.84M
FCNCA icon
2693
First Citizens BancShares
FCNCA
$25.7B
-12,600
Closed -$10.5M
VNET
2694
VNET Group
VNET
$2.11B
-195,320
Closed -$1.76M
WBS icon
2695
Webster Financial
WBS
$12.8B
-199,400
Closed -$11.1M
APR
2696
DELISTED
Apria, Inc. Common Stock
APR
-38,800
Closed -$1.26M
CONE
2697
DELISTED
CyrusOne Inc Common Stock
CONE
-272,899
Closed -$24.5M
FRTA
2698
DELISTED
Forterra, Inc
FRTA
-65,700
Closed -$1.56M
KRA
2699
DELISTED
Kraton Corporation
KRA
-71,000
Closed -$3.29M
ARNA
2700
DELISTED
Arena Pharmaceuticals Inc
ARNA
-127,705
Closed -$11.9M

Similar funds

Swiss National Bank's Q1 2022 Portfolio in Review

As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.

  • Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
  • Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
  • Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
  • Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
  • Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
  • Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
  • Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.

Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.